Health

Residents at the Hospital of University of Pennsylvania and Pennsylvania Hospital have joined a growing number of physician unionization efforts.

When your caretakers can’t even get care, something is seriously wrong.

The first year of settlement funds from national opioid lawsuits have reached Camden County, where officials will prioritize treatment and naloxone access.

The nearly $80 million grant will help Nemours Children's Hospital focus on long-overlooked patients with cancer, blood illness, and sickle cell disease.

President Joe Biden brought up that cost cap during his annual State of the Union address last month. He called for insulin costs for everyone to be capped at $35.

Researchers said he suffered from stage 4 CTE, which is the most advanced kind of the disease. Cross was diagnosed with mild cognitive dementia in 2018.

The FDA is considering a nonprescription, over-the-counter version of Narcan’s nasal spray for opioid overdoses. But experts worry about affordability.

The at-home nasal swab kit simultaneously tests for COVID-19 and two strains of the flu.

Anxiety disorders are on the rise in this country, especially since the pandemic. What are the reasons for this steep increase? In ...

It seems like every day, new skin care products hit the market: lotions, serums, collagen boosters, light therapy, at-home lasers — pot ...

A new microneedling technique utilizes a solution based on human stem cells to increase the treatment’s effect. WHYY’s host of The Pulse, Maiken Scott, gave it a try.

Medication abortions in the United States usually involve two different drugs. In the latest effort to limit abortion access, opponents are seeking to ban one of those.

Demand for COVID-19 vaccines has faded, but local health workers are trying to get more people up-to-date with their immunization.

Experts say depression occurs after a stroke in about 1 in 3 patients. There may be a biological reason, with some evidence suggesting that strokes might cause brain changes.

Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. But the price tag could prove to be a barrier for many.